Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
carbonic anhydrase inhibitor |
| gptkbp:approvedBy |
1995
|
| gptkbp:ATCCode |
S01EC03
|
| gptkbp:brand |
gptkb:Trusopt
|
| gptkbp:CASNumber |
130693-82-2
|
| gptkbp:chemicalFormula |
C10H17N3O4S3·HCl
|
| gptkbp:contraindication |
hypersensitivity to sulfonamides
|
| gptkbp:discoveredBy |
gptkb:Merck_&_Co.
|
| https://www.w3.org/2000/01/rdf-schema#label |
Dorzolamide hydrochloride
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits carbonic anhydrase II in the ciliary processes of the eye
|
| gptkbp:molecularWeight |
360.91 g/mol
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:reduces |
intraocular pressure
|
| gptkbp:routeOfAdministration |
topical (eye drops)
|
| gptkbp:sideEffect |
blurred vision
bitter taste eye irritation |
| gptkbp:usedFor |
treatment of glaucoma
treatment of ocular hypertension |
| gptkbp:bfsParent |
gptkb:dorzolamide
|
| gptkbp:bfsLayer |
6
|